本页面由Tiger Trade Technology Pte. Ltd.提供服务

Solid Biosciences

8.39
+0.07000.84%
盘后8.23-0.1600-1.91%18:12 EDT
成交量:67.27万
成交额:559.05万
市值:8.26亿
市盈率:-4.21
高:8.43
开:8.26
低:8.06
收:8.32
52周最高:8.87
52周最低:2.41
股本:9,839.13万
流通股本:5,854.24万
量比:0.56
换手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-1.9922
每股收益(LYR):-3.0550
净资产收益率:-109.90%
总资产收益率:-53.18%
市净率:4.59
市盈率(LYR):-2.75

数据加载中...

2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/20

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2023/01/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/09

重要事件披露

8-K - Current report
2022/12/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

重要事件披露

8-K - Current report
2022/12/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership